TLR3 and asthma: Interestingly, treatment with CNTO3157, an inhibitory monoclonal antibody to Toll-like receptor 3 (TLR3), failed to prevent an RV-induced fall in FEV1 and airway symptoms in subjects with asthma but ameliorated symptoms in healthy subjects [110].